Evaluation of Ranibizumab in Proliferative Diabetic Retinopathy (PDR) Requiring Vitrectomy

NCT00516464 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Proliferative Diabetic Retinopathy

Interventions

DRUG: Lucentis (ranibizumab)

Sponsor

Retina Associates, Kansas City

Collaborators

[object Object]